In summary, a sensitive electrochemical biosensor was successfully developed to detect and quantify CSTB, LTA4H, and COL6A1 biomarkers in noninvasive saliva samples from OSCC patients, with and without lymph node metastasis. The gene discussed is CSTB; the disease is metastatic malignant neoplasm in the lymph nodes.